PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
PU.1 is a B-cell- and macrophage-specific transcription factor. By an electrophoretic mobility shift assay and dimethyl sulfate methylation interference assays, we show that PU.1 binds to DNA sequences within the immunoglobulin kappa 3' enhancer (kappa E3'). Binding of PU.1 to the kappa E3' enhancer assists the binding of a second tissue-restricted factor, NF-EM5, to an adjacent site. Binding of NF-EM5 to kappa E3' DNA sequences requires protein-protein interaction with PU.1 as well as specific protein-DNA interactions. This is the first known instance of PU.1 interacting with another cellular protein. NF-EM5 does not cofractionate with PU.1, suggesting that it is a distinct protein and is not a posttranslational modification of PU.1. UV-crosslinking studies and elution from sodium dodecyl sulfate-polyacrylamide gels indicate that NF-EM5 is a protein of approximately 46 kDa. Site-directed mutagenesis studies of the PU.1- and EM5-binding sites indicate that these sites play important roles in kappa E3' enhancer activity. By using a series of PU.1 deletion constructs, we have identified a region in PU.1 that is necessary for interaction with NF-EM5. This segment encompasses a 43-amino-acid region with PEST sequence homology, i.e., one that is rich in proline (P), glutamic acid (E), serine (S), and threonine (T).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,399 · cited 1×
“was generated by overlap extension by using the polymerase chain reaction (16).”
MethodThe Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114 · cited 2×
“Several major groups which include zinc finger domains, homeodomains, and basic region domains have been identified (9, 20, 29).”
BackgroundMurre, C., McCaw, P. S., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90682-x · Cited by 2,635 · cited 7×
“PU.1 does not contain sequences homologous to known dimerization domains (leucine zipper and HLH), and thus far there have been no reports of PU.1 interacting with other proteins.”
BackgroundInfluentialAmino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537 · cited 2×
“Regions rich in these amino acids have been denoted PEST regions, and they may be involved in degradation of intracellular proteins (37).”
BackgroundThe protein Id: A negative regulator of helix-loop-helix DNA binding proteins
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., & Weintraub, H. (1990) · Cell · doi:10.1016/0092-8674(90)90214-y · Cited by 2,238 · cited 1×
“Thus, mammalian muscle differentiation and the Drosophila sensory organ patterning pathways can be greatly influenced by the presence of certain HLH dimerization partners (3, 8, 10).”
BackgroundHow eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N., Hauschka, S. D., Lassar, A. B., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90434-0 · Cited by 1,815
Cited by
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
“Both promoter-proximal and promoter-distal commonly PU.1-bound regions exhibited enrichment for a PU.1:IRF composite, consistent with the ability of PU.1 and IRF4/8 to form a ternary complex on this class of composite sites in both cell types (Eisenbeis et al., 1993; Pongubala et al., 1992).”
BackgroundIRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., Hoffmann, M., Ulges, A., Taube, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.07.014 · Cited by 554
Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression
Kallies, A., Hasbold, J., Tarlinton, D. M., Dietrich, W., Corcoran, L. M., Hodgkin, P. D., & Nutt, S. L. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040973 · Cited by 531
Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Regulatory Mechanisms that Determine the Development and Function of Plasma Cells
Calame, K. L., Lin, K.-I., & Tunyaplin, C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141138 · Cited by 370
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Zhang, P., Zhang, X., Iwama, A., Yu, C., Smith, K. A., Mueller, B. U., Narravula, S., Torbett, B. E., Orkin, S. H., & Tenen, D. G. (2000) · Blood · doi:10.1182/blood.v96.8.2641 · Cited by 368
Nye, J. A., Petersen, J. M., Gunther, C. V., Jonsen, M. D., & Graves, B. J. (1992) · Genes & Development · doi:10.1101/gad.6.6.975 · Cited by 363
Bailly, R.-A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., & Ghysdael, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3230-3241.1994 · Cited by 297
Specificity within the ets Family of Transcription Factors
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60738-1 · Cited by 344
Macleod, K., Leprince, D., & Stehelin, D. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90404-w · Cited by 304
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301
Self-citationSignal integration between IFNγ and TLR signalling pathways in macrophages
Schroder, K., Sweet, M. J., & Hume, D. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.007 · Cited by 288
Hohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5830 · Cited by 284
“1 (amino acids 33 to 45 of the murine protein) was provided by Richard Maki (24, 46), and an antiserum raised against the full-length PU.”
BackgroundMethodResultInfluentialACCESSIBILITY CONTROL OF ANTIGEN-RECEPTOR VARIABLE-REGION GENE ASSEMBLY: Role of cis-Acting Elements
Sleckman, B. P., Gorman, J. R., & Alt, F. W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.459 · Cited by 290
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 271
Self-citationIRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development
Lu, R., Medina, K. L., Lancki, D. W., & Singh, H. (2003) · Genes & Development · doi:10.1101/gad.1104803 · Cited by 275
“…members of the interferon regulatory factor (IRF) family that have been implicated in regulating immunoglobulin (Ig) light-chain gene transcription during B-lymphocyte development (Pongubala et al. 1992; Eisenbeis et al. 1995; Shaffer et al. 1997; Brass et al. 1999; Muljo and Schlissel 2002).”
BackgroundJohannsen, E., Koh, E., Mosialos, G., Tong, X., Kieff, E., & Grossman, S. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.253-262.1995 · Cited by 249
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
Mueller, B. U., Pabst, T., Osato, M., Asou, N., Johansen, L. M., Minden, M. D., Behre, G., Hiddemann, W., Ito, Y., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v100.3.998 · Cited by 243
Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242
Regulation of Ets function by protein–protein interactions
Li, R., Pei, H., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204035 · Cited by 229
“…et al., 2000 GATA-2 PU.1 R Zhang et al., 1999 NF-EM5(Pip) Spi-1/PU.1 Ig L A Brass et al., 1996 Enhancer Ortiz et al., 1999 Perkel and Atchison, 1998 Pongubala et al., 1992 TFE3 Ets1/PU.1 Ig m A Tian et al., 1999 enhancer Dang et al., 1998 PEBP2aB Ets1 TcRa A Wooton et al., 1994 /AML1/ Giese et…”
BackgroundTranscription Factors and Hematopoietic Development
Orkin, S. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.4955 · Cited by 228
The genetic network controlling plasma cell differentiation
Nutt, S. L., Taubenheim, N., Hasbold, J., Corcoran, L. M., & Hodgkin, P. D. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.010 · Cited by 226
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R. (1993) · Science · doi:10.1126/science.8316859 · Cited by 222
Self-citationIRF4 at the crossroads of effector T‐cell fate decision
Huber, M., & Lohoff, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201344279 · Cited by 221
Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1
Petrovick, M. S., Hiebert, S. W., Friedman, A. D., Hetherington, C. J., Tenen, D. G., & Zhang, D.-E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3915 · Cited by 218
“mAML1A(1-288) is terminated at amino acid 288 of AML1A.”
BackgroundMethodInfluentialHematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1
Hromas, R., Orazi, A., Neiman, R., Maki, R., Van Beveran, C., Moore, J., & Klemsz, M. (1993) · Blood · doi:10.1182/blood.v82.10.2998.2998 · Cited by 216
Self-citationCooperative binding of Ets-1 and core binding factor to DNA.
Wotton, D., Ghysdael, J., Wang, S., Speck, N. A., & Owen, M. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.840 · Cited by 216
Hollenhorst, P. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh906 · Cited by 214
Thyroid-specific gene expression
Damante, G., & Di Lauro, R. (1994) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)90176-7 · Cited by 224
Regulation of interleukin-12 production in antigen-presenting cells
Mal, X., & Trinchieri, G. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)79002-5 · Cited by 214
Brass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 204
“The lymphoid-restricted interferon regulatory factor, Pip (IRF-4), and the hematopoietic-specific Ets protein, PU.1, form complexes in B cells on composite elements present in immunoglobulin light chain (IgL) gene enhancers (Pongubala et al., 1992; Eisenbeis et al., 1993).”
BackgroundJousset, C., Carron, C., Boureux, A., Quang, C. T., Oury, C., Dusanter‐Fourt, I., Charon, M., Levin, J., Bernard, O., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.1.69 · Cited by 207
Sp1 is a critical factor for the monocytic specific expression of human CD14
Zhang, D. E., Hetherington, C. J., Tan, S., Dziennis, S. E., Gonzalez, D. A., Chen, H. M., & Tenen, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78141-1 · Cited by 194
Gene regulation by Ets proteins
Janknecht, R. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90014-4 · Cited by 192
Johnson, K., Hashimshony, T., Sawai, C. M., Pongubala, J. M. R., Skok, J. A., Aifantis, I., & Singh, H. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.019 · Cited by 189
“In contrast, the Igk locus has two distinct enhancers, the intronic enhancer (iEk) and the 30 enhancer (30Ek); only the latter contains a functional Ets-IRF composite binding site for IRF-4,8 (Pongubala et al., 1992).”
BackgroundInfluentialSelf-citationSpi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189
“... (43) and FcgRIIIA (14) receptors for immunoglobulin G, the integrin cell surface receptor CD11b (40), the c-Fes/c-Fps tyrosine kinase (49), and its own promoter(8).Spi-1/PU.1bindingsitesalsoexistintheenhancerof the interleukin-4 (IL-4) gene in mast cells (20) and in the enhancer-promoter of genes expressed during…”
BackgroundIRF4: Immunity. Malignancy! Therapy?
Shaffer, A. L., Emre, N. C. T., Romesser, P. B., & Staudt, L. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1845 · Cited by 189
Lee, C. H., Melchers, M., Wang, H., Torrey, T. A., Slota, R., Qi, C.-F., Kim, J. Y., Lugar, P., Kong, H. J., Farrington, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051450 · Cited by 187
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis
Burda, P., Laslo, P., & Stopka, T. (2010) · Leukemia · doi:10.1038/leu.2010.104 · Cited by 184
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38
Defective B cell receptor‐mediated responses in mice lacking the Ets protein, Spi‐B
Su, G. H., Chen, H., Muthusamy, N., Garrett‐Sinha, L. A., Baunoch, D., Tenen, D. G., & Simon, M. C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7118 · Cited by 182
“…and myeloid development have been identified as putative PU.1 target genes: Ig heavy chain (μ) (Nelsen et al., 1993), Ig light chains (κ and λ) (Pongubala et al., 1992; Eisenbeis et al., 1993), mb-1 (Igα) (Feldhaus et al., 1992; Hagman and Grosschedl, 1992), B29 (Igβ) (Omori and Wall,…”
BackgroundSumoylation of Oct4 Enhances Its Stability, DNA Binding, and Transactivation
Wei, F., Schoöler, H. R., & Atchison, M. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611041200 · Cited by 180
Self-citationEklund, E. A., Jalava, A., & Kakar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13957 · Cited by 176
Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element
Okuno, Y., Huang, G., Rosenbauer, F., Evans, E. K., Radomska, H. S., Iwasaki, H., Akashi, K., Moreau-Gachelin, F., Li, Y., Zhang, P., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2832-2845.2005 · Cited by 174
“PU.1 also regulates activities of immunoglobulin G (IgG) and enhancers that are essential for lymphoid commitment (39, 46 ).”
Backgroundvan Zelm, M. C., van der Burg, M., de Ridder, D., Barendregt, B. H., de Haas, E. F. E., Reinders, M. J. T., Lankester, A. C., Révész, T., Staal, F. J. T., & van Dongen, J. J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5912 · Cited by 174
Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1.
Gégonne, A., Bosselut, R., Bailly, R. A., & Ghysdael, J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05758.x · Cited by 169
The Igκ 3′ Enhancer Influences the Ratio of Igκ versus Igλ B Lymphocytes
Gorman, J. R., van der Stoep, N., Monroe, R., Cogne, M., Davidson, L., & Alt, F. W. (1996) · Immunity · doi:10.1016/s1074-7613(00)80319-2 · Cited by 167
Muljo, S. A., & Schlissel, M. S. (2003) · Nature Immunology · doi:10.1038/ni870 · Cited by 167
“The Igk locus contains a well described EICE within its 3′ enhance”
BackgroundETS transcription factors and regulation of immunity
Gallant, S., & Gilkeson, G. (2006) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-006-0017-z · Cited by 163
The transcription factor PU.1 is involved in macrophage proliferation.
Celada, A., Borràs, F. E., Soler, C., Lloberas, J., Klemsz, M., van Beveren, C., McKercher, S., & Maki, R. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.61 · Cited by 152
Self-citationAccessibility Control of V(D)J Recombination
Cobb, R. M., Oestreich, K. J., Osipovich, O. A., & Oltz, E. M. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)91002-5 · Cited by 160
Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.
Donaldson, L. W., Petersen, J. M., Graves, B. J., & McIntosh, L. P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00340.x · Cited by 161
“Partnerships between ets proteins and transcription factors belonging to other structural families have served to establish general principles for cooperative protein-protein interactions in the control of gene expression (Thompson et al., 1991; Pongubala et al., 1992; Janknecht and Nordheim, 1993; Wasylyk et al., 199…”
BackgroundFisher, R. C., & Scott, E. W. (1998) · STEM CELLS · doi:10.1002/stem.160025 · Cited by 158
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1.
Ray, D., Bosselut, R., Ghysdael, J., Mattei, M. G., Tavitian, A., & Moreau-Gachelin, F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4297 · Cited by 157
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 177
“1 peptide sequence rich in proline, glutamic acid, serine, and threonine (105, 108).”
BackgroundThe transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation
Carotta, S., Willis, S. N., Hasbold, J., Inouye, M., Pang, S. H. M., Emslie, D., Light, A., Chopin, M., Shi, W., Wang, H., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140425 · Cited by 155
“As PU.1 and IRF proteins (both IRF4 and 8) are well known to cooperatively bind to composite DNA recognition motifs (Pongubala et al., 1992; Eisenbeis et al., 1993; Kanno et al., 2005), we have addressed the importance of this interaction by creating mice in which IRF8 and PU.1 are deleted in B…”
BackgroundReddy, V. A., Iwama, A., Iotzova, G., Schulz, M., Elsasser, A., Vangala, R. K., Tenen, D. G., Hiddemann, W., & Behre, G. (2002) · Blood · doi:10.1182/blood.v100.2.483 · Cited by 152
Galson, D. L., Hensold, J. O., Bishop, T. R., Schalling, M., D'Andrea, A. D., Jones, C., Auron, P. E., & Housman, D. E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2929-2941.1993 · Cited by 45
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
Self-citationKominato, Y., Galson, D. L., Waterman, W. R., Webb, A. C., & Auron, P. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.59 · Cited by 151
“The peptide consisting of amino acids 118 to 160 has been demonstrated, when phosphorylated at S-148, to bind factor NF-EM5, which is essential for the function of the Igk and Igl gene downstream enhancers (9, 27, 28).”
BackgroundMethodInfluentialHagman, J., & Grosschedl, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8889 · Cited by 143
The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages
Lloberas, J., Soler, C., & Celada, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01442-5 · Cited by 142
Inhibition of hematopoiesis by competitive binding of transcription factor PU.1
Voso, M. T., Burn, T. C., Wulf, G., Lim, B., Leone, G., & Tenen, D. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.7932 · Cited by 141
The diverse roles of IRF4 in late germinal center B‐cell differentiation
De Silva, N. S., Simonetti, G., Heise, N., & Klein, U. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01113.x · Cited by 143
“1 binding site in the jE3¢ enhancer sequence (1).”
BackgroundInfluentialMolecular phylogeny of the ETS gene family
Laudet, V., Hänni, C., Stéhelin, D., & Duterque-Coquillaud, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202444 · Cited by 139
“…have been the subject of extensive investigation because of their ability to regulate various kinds of genes, including immune response genes (Pongubala et al.,1992; Rivera et al., 1993), other oncogenes or genes encoding matrix-degrading proteases (Rorth et al., 1990; Wasylyk et al., 1991;…”
BackgroundWu, H., Moulton, K., Horvai, A., Parik, S., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2129 · Cited by 46
IFN Regulatory Factor 4 Regulates the Expression of a Subset of Th2 Cytokines
Ahyi, A.-N. N., Chang, H.-C., Dent, A. L., Nutt, S. L., & Kaplan, M. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803302 · Cited by 137
Laux, G., Adam, B.-L., Strobl, L. J., & Moreau-Gachelin, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06900.x · Cited by 151
Ma, X., Neurath, M., Gri, G., & Trinchieri, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10389 · Cited by 138
Colucci, F., Samson, S. I., DeKoter, R. P., Lantz, O., Singh, H., & Di Santo, J. P. (2001) · Blood · doi:10.1182/blood.v97.9.2625 · Cited by 136
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS
Hallier, M., Lerga, A., Barnache, S., Tavitian, A., & Moreau-Gachelin, F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4838 · Cited by 136
TRANSCRIPTIONAL REGULATION DURING B CELL DEVELOPMENT
Henderson, A., & Calame, K. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.163 · Cited by 137
ISGF3γ p48, a specificity switch for interferon activated transcription factors
Bluyssen, H. A. R. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00005-6 · Cited by 158
Fletcher, J. C., Burtis, K. C., Hogness, D. S., & Thummel, C. S. (1995) · Development · doi:10.1242/dev.121.5.1455 · Cited by 133
Ford, A. M., Bennett, C. A., Healy, L. E., Towatari, M., Greaves, M. F., & Enver, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10838 · Cited by 134
The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., & Thompson, C. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32437-7 · Cited by 132
Lineage-Specific Modulation of Interleukin 4 Signaling by Interferon Regulatory Factor 4
Gupta, S., Jiang, M., Anthony, A., & Pernis, A. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1837 · Cited by 130
“Our inability to detect a cooperative complex containing both IRF-4 and Stat6 also contrasts with the strong phosphorylation-dependent cooperative interaction between IRF-4 and the Ets protein, PU.1 (29, 35 , 36).”
BackgroundTorlakovic, E., Tierens, A. M., Dang, H. D., & Delabie, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63027-1 · Cited by 160
Essential role of interferon regulatory factor 4 (IRF4) in immune cell development
Nam, S., & Lim, J. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0854-1 · Cited by 138
“IRF4 (also known as LSIRF, PIP, and MUM1) was origi- nally identified as a nuclear factor interacting with PU.1 (Pongubala et al. 1992).”
BackgroundInfluentialReddy, M. A., Yang, B. S., Yue, X., Barnett, C. J., Ross, I. L., Sweet, M. J., Hume, D. A., & Ostrowski, M. C. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2309 · Cited by 123
“1 expression in B cells did not transactivate a PU-box multimer from the IgkY enhancer unless the adjacent binding site for another factor, NF-EM5 was included (9).”
BackgroundPU.1 and Spi-B Are Required for Normal B Cell Receptor–Mediated Signal Transduction
Garrett‐Sinha, L. A., Su, G. H., Rao, S., Kabak, S., Hao, Z., Clark, M. R., & Simon, M. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80040-0 · Cited by 138
Eichbaum, Q. G., Iyer, R., Raveh, D. P., Mathieu, C., & Ezekowitz, R. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1985 · Cited by 86
“PU.1 has been shown to function in association with other factors ( 31 , 33, 34, 36, 46).”
BackgroundMethodInfluentialNakajima, K., Kusafuka, T., Takeda, T., Fujitani, Y., Nakae, K., & Hirano, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.3027 · Cited by 119
Lopez, M., Oettgen, P., Akbarali, Y., Dendorfer, U., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3292 · Cited by 120
The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M., Chen, H. M., & Simon, M. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.203 · Cited by 115
“c-fes (15) GATCAAACCGCGGGAGGAGGAAGCGCGGAATCAGGA c-fes mutant (15) GATCAAACCGCGGGAGCACCGGGCGCGGAATCAGGA SV40 (12) GATCTCGGGCTCGAGTCTGAAAGAGGAACTTGGTTA SV40 mutant (12) GATCTCGGGCTCGAGTCTTGAAAGACCAACTTGGTT Ig~-3' enhancer (16) GATCCCTTTGAGGAACTGAAAACAGAACCTAGATC IgJ chain (17) CTAGATTTTAAGAAAGCAGAAGCAGCAT M-CSF receptor…”
BackgroundMarecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111
“As previously shown for other composite elements (28, 29), DNA binding by IRF proteins was not observed in the absence of PU.”
InfluentialScheller, M., Foerster, J., Heyworth, C. M., Waring, J. F., Löhler, J., Gilmore, G. L., Shadduck, R. K., Dexter, T. M., & Horak, I. (1999) · Blood · doi:10.1182/blood.v94.11.3764 · Cited by 111
Spi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110
The Role of Ets Transcription Factors in the Development and Function of the Mammalian Immune System
Bassuk, A. G., & Leiden, J. M. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60887-1 · Cited by 125
Aronow, B. J., Silbiger, R. N., Dusing, M. R., Stock, J. L., Yager, K. L., Potter, S. S., Hutton, J. J., & Wiginton, D. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4170 · Cited by 107
The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb
Hallier, M., Tavitian, A., & Moreau-Gachelin, F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11177 · Cited by 104
Zhao, B., & Sample, C. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5151-5160.2000 · Cited by 121
Metadata
- Authors
- Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1992-01
- Volume
- 12
- Issue
- 1
- Pages
- 368-378
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364131
- OpenAlex
- W1909754239
- Cited by
- 354
- References
- 48
- Citations by year
- 2025: 2 · 2023: 1 · 2022: 6 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 1 · 2012: 7
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ai030656-08)
- National Institute of General Medical Sciences (R01GM042415)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- PU.1, enhancer activity, transcription factor binding sites, protein-protein interaction, PEST sequence, DNA binding specificity
- MeSH terms
- Base Sequence, Binding Sites, Cell Line, DNA, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Enhancer Elements, Genetic, Immunoglobulin kappa-Chains, Molecular Sequence Data, Nuclear Proteins, Organ Specificity, Transcription Factors, Retroviridae Proteins, Oncogenic, Mutagenesis, Site-Directed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.